IsproniclineA novel α4β2 nicotinic acetylcholine receptor-selective agonist with cognition-enhancing and neuroprotective properties

被引：0
|
作者：
Patrick Lippiello
Sharon R. Letchworth
Gregory J. Gatto
Vincent M. Traina
Merouane Bencherif
机构：
[1] Targacept,Preclinical Research
[2] Inc.,undefined
来源：
Journal of Molecular Neuroscience | 2006年 / 30卷
关键词：
Nicotinic Acetylcholine Receptor; Molecular Neuroscience Volume; Striatal Dopamine Release; Neuronal nAChR; nAChR Agonist;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：19 / 20
页数：1
相关论文
共 50 条
  • [1] Ispronicline -: A novel α4β2 nicotinic acetylcholine receptor-selective agonist with cognition-enhancing and neuroprotective properties
    Lippiello, Patrick
    Letchworth, Sharon R.
    Gatto, Gregory. J.
    Traina, Vincent M.
    Bencherif, Merouane
    JOURNAL OF MOLECULAR NEUROSCIENCE, 2006, 30 (1-2) : 19 - 20
  • [2] An allosteric modulator of the α7 nicotinic acetylcholine receptor possessing cognition-enhancing properties in vivo
    Timmermann, Daniel B.
    Gronlien, Jens Halvard
    Kohlhaas, Kathy L.
    Nielsen, Elsebet O.
    Dam, Eva
    Jorgensen, Tino D.
    Ahring, Philip K.
    Peters, Dan
    Holst, Dorte
    Chrsitensen, Jeppe K.
    Malysz, John
    Briggs, Clark A.
    Gopalakrishnan, Murali
    Olsen, Gunnar M.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2007, 323 (01): : 294 - 307
  • [3] Preclinical characterization of A-582941: A novel α7 neuronal nicotinic receptor agonist with broad spectrum cognition-enhancing properties
    Tietje, Karin R.
    Anderson, David J.
    Bitner, R. Scott
    Blomme, Eric A.
    Brackemeyer, Paul J.
    Briggs, Clark A.
    Browman, Kaitlin E.
    Bury, Dagmar
    Curzon, Peter
    Drescher, Karla U.
    Frost, Jennifer M.
    Fryer, Ryan M.
    Fox, Gerard B.
    Gronlien, Jens Halvard
    Hakerud, Monika
    Gubbins, Earl J.
    Halm, Sabine
    Harris, Richard
    Helfrich, Rosalind J.
    Kohlhaas, Kathy L.
    Law, Devalina
    Malysz, John
    Marsh, Kennan C.
    Martin, Ruth L.
    Meyer, Michael D.
    Molesky, Angela L.
    Nikkel, Arthur L.
    Otte, Stephani
    Pan, Liping
    Puttfarcken, Pamela S.
    Radek, Richard J.
    Robb, Holly M.
    Spies, Eva
    Thorin-Hagene, Kirsten
    Waring, Jeffrey F.
    Ween, Hilde
    Xu, Hongyu
    Gopalakrishnan, Murali
    Bunnelle, William H.
    CNS NEUROSCIENCE & THERAPEUTICS, 2008, 14 (01) : 65 - 82
  • [4] Molecular dissection of tropisetron, an α7 nicotinic acetylcholine receptor-selective partial agonist
    Papke, RL
    Schiff, HC
    Jack, BA
    Horenstein, NA
    NEUROSCIENCE LETTERS, 2005, 378 (03) : 140 - 144
  • [5] Novel Acetylcholine and Carbamoylcholine Analogues: Development of a Functionally Selective α4β2 Nicotinic Acetylcholine Receptor Agonist
    Hansen, Camilla P.
    Jensen, Anders A.
    Christensen, Jeppe K.
    Balle, Thomas
    Lijefors, Tommy
    Frolund, Bente
    JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (23) : 7380 - 7395
  • [6] SL65.0155, a novel 5-hydroxytryptamine4 receptor partial agonist with potent cognition-enhancing properties
    Moser, PC
    Bergis, OE
    Jegham, S
    Lochead, A
    Duconseille, E
    Terranova, JP
    Caille, D
    Berque-Bestel, I
    Lezoualc'h, F
    Fischmeister, R
    Dumuis, A
    Bockaert, J
    George, P
    Soubrié, P
    Scatton, B
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 302 (02): : 731 - 741
  • [7] An Allosteric Modulator of the α7 Nicotinic Acetylcholine Receptor Possessing Cognition-Enhancing Properties in Vivo (vol 323, pg 294, 2007)
    Timmerman, D. B.
    Gronlien, J. H.
    Kohlhaas, K. L.
    Nielsen, E. O.
    Dam, E.
    Jorgensen, T. D.
    Ahring, P. K.
    Peters, D.
    Holst, D.
    Christensen, J. K.
    Malysz, J.
    Briggs, C. A.
    Gopalakrishnan, M.
    Olsen, G. M.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2009, 331 (03): : 1146 - 1146
  • [8] An α7 Nicotinic Acetylcholine Receptor-Selective Agonist Reduces Weight Gain and Metabolic Changes in a Mouse Model of Diabetes
    Marrero, Mario B.
    Lucas, Rudolf
    Salet, Christina
    Hauser, Terry A.
    Mazurov, Anatoly
    Lippiello, Patrick M.
    Bencherif, Merouane
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2010, 332 (01): : 173 - 180
  • [9] Ispronicline.: Nicotinic acetylcholine α4β2 agonist, Treatment of cognition disorders
    Owen, R. T.
    Serradell, N.
    Rosa, E.
    DRUGS OF THE FUTURE, 2008, 33 (03) : 197 - 202
  • [10] An allosteric modulator of the α7 nicotinic acetylcholine receptor possessing cognition enhancing properties in vivo
    Timmermann, Daniel B.
    Gronlien, Jens Halvard
    Kohlhaas, Kathy L.
    Nielsen, Elsebet O.
    Dam, Eva
    Jorgensen, Tino D.
    Ahring, Philip K.
    Peters, Dan
    Holst, Dorte
    Christensen, Jeppe K.
    Malysz, John
    Briggs, Clark A.
    Gopalakrishnan, Murali
    Olsen, Gunnar M.
    BIOCHEMICAL PHARMACOLOGY, 2007, 74 (08) : SMA33 - SMA34
12345